XML 31 R21.htm IDEA: XBRL DOCUMENT v3.23.2
Summary of Significant Accounting Policies (Tables)
 6 Months Ended
Jun. 30, 2023
Summary of Significant Accounting Policies [Abstract]  
Schedule of Accounts and Grants Receivable Accounts and grants receivable by source, as of (in thousands):
   June 30,
2023		   December 31,
2022		 
National Institutes of Health – Grant  $96   $  218 
Total  $96   $218 
Schedule of Revenue Revenue by source (in thousands):
   Three months ended
 June 30,		   Six months ended
June 30,		 
   2023   2022   2023   2022 
National Institute of Health - grant  $
-
   $41   $41   $82 
Clinical trial revenue   217    340    455    650 
MSCRF – TEDCO1 - grant   
-
    85    
-
    104 
Total  $217   $466   $496   $836 
1Maryland Stem Cell Research Fund (MSCRF) - Maryland Technology Development Corporation (TEDCO)